FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2791443664> ?p ?o ?g. }

• W2791443664 endingPage "1404" @default.
• W2791443664 startingPage "1398" @default.
• W2791443664 abstract "This study was performed with the aim of determining the long-term immunogenicity of an inactivated, Vero cell culture-derived Japanese encephalitis (JE) vaccine (JE-VC) and an inactivated, mouse brain-derived JE vaccine (JE-MB) after the 1st booster dose at 2 years of age, as well as the safety and immunogenicity of the 2nd booster dose of JE-VC at 6 years of age, in children primed and given a 1st booster dose of either JE-VC or JE-MB. In this multicenter, open-label clinical trial, the study population consisted of healthy Korean children (aged 6 years) who participated in the previous JE vaccine trial. All subjects were subcutaneously vaccinated once for the booster immunization with Boryung Cell Culture Japanese Encephalitis Vaccine® (JE-VC). Approximately 4 years after the 1st booster dose of JE-VC, the seroprotection rate (SPR) and geometric mean titer (GMT) of the neutralizing antibody were 100% and 1113.8, respectively. In children primed and given a 1st booster dose of JE-MB, the SPR and GMT were 88.5% and 56.3, respectively. After the 2nd booster dose of JE-VC, all participants primed and given a 1st booster dose of either JE-MB or JE-VC were seroprotective against JE virus. The GMT of the neutralizing antibody was higher in children primed and given a 1st booster dose of JE-VC (8144.1) than in those primed and given a 1st booster dose of JE-MB (942.5) after the vaccination (p < 0.001). In addition, the 2nd booster dose of JE-VC showed a good safety profile with no serious vaccine-related adverse events. The 1st booster dose of JE-VC and JE-MB showed long-term immunogenicity of at least 4 years, and the 2nd booster dose of JE-VC showed a good safety and immunogenicity profile in children primed and given a 1st booster dose of either JE-VC or JE-MB. ClinicalTtrials.gov Identifier: NCT02532569" @default.
• W2791443664 created "2018-03-29" @default.
• W2791443664 creator A5013694438 @default.
• W2791443664 creator A5024721443 @default.
• W2791443664 creator A5030667338 @default.
• W2791443664 creator A5035031201 @default.
• W2791443664 creator A5035212965 @default.
• W2791443664 creator A5039552388 @default.
• W2791443664 creator A5041698666 @default.
• W2791443664 creator A5049046821 @default.
• W2791443664 creator A5050866517 @default.
• W2791443664 creator A5059751257 @default.
• W2791443664 creator A5077093336 @default.
• W2791443664 date "2018-03-01" @default.
• W2791443664 modified "2023-09-27" @default.
• W2791443664 title "Long-term immunogenicity of an initial booster dose of an inactivated, Vero cell culture-derived Japanese encephalitis vaccine (JE-VC) and the safety and immunogenicity of a second JE-VC booster dose in children previously vaccinated with an inactivated, mouse brain-derived Japanese encephalitis vaccine" @default.
• W2791443664 cites W1967677491 @default.
• W2791443664 cites W1970835398 @default.
• W2791443664 cites W1975259638 @default.
• W2791443664 cites W1987172583 @default.
• W2791443664 cites W1994240161 @default.
• W2791443664 cites W2001518627 @default.
• W2791443664 cites W2005880433 @default.
• W2791443664 cites W2010549874 @default.
• W2791443664 cites W2014571326 @default.
• W2791443664 cites W2017965265 @default.
• W2791443664 cites W2056233716 @default.
• W2791443664 cites W2087963165 @default.
• W2791443664 cites W2090157651 @default.
• W2791443664 cites W2103126826 @default.
• W2791443664 cites W2126293417 @default.
• W2791443664 cites W2132290947 @default.
• W2791443664 cites W2153749949 @default.
• W2791443664 cites W2161853178 @default.
• W2791443664 cites W2167921215 @default.
• W2791443664 cites W2317968120 @default.
• W2791443664 cites W406323068 @default.
• W2791443664 cites W94984062 @default.
• W2791443664 doi "https://doi.org/10.1016/j.vaccine.2018.01.075" @default.
• W2791443664 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29429815" @default.
• W2791443664 hasPublicationYear "2018" @default.
• W2791443664 type Work @default.
• W2791443664 sameAs 2791443664 @default.
• W2791443664 citedByCount "8" @default.
• W2791443664 countsByYear W27914436642020 @default.
• W2791443664 countsByYear W27914436642021 @default.
• W2791443664 countsByYear W27914436642022 @default.
• W2791443664 countsByYear W27914436642023 @default.
• W2791443664 crossrefType "journal-article" @default.
• W2791443664 hasAuthorship W2791443664A5013694438 @default.
• W2791443664 hasAuthorship W2791443664A5024721443 @default.
• W2791443664 hasAuthorship W2791443664A5030667338 @default.
• W2791443664 hasAuthorship W2791443664A5035031201 @default.
• W2791443664 hasAuthorship W2791443664A5035212965 @default.
• W2791443664 hasAuthorship W2791443664A5039552388 @default.
• W2791443664 hasAuthorship W2791443664A5041698666 @default.
• W2791443664 hasAuthorship W2791443664A5049046821 @default.
• W2791443664 hasAuthorship W2791443664A5050866517 @default.
• W2791443664 hasAuthorship W2791443664A5059751257 @default.
• W2791443664 hasAuthorship W2791443664A5077093336 @default.
• W2791443664 hasConcept C121332964 @default.
• W2791443664 hasConcept C12590561 @default.
• W2791443664 hasConcept C1276947 @default.
• W2791443664 hasConcept C159047783 @default.
• W2791443664 hasConcept C159654299 @default.
• W2791443664 hasConcept C203014093 @default.
• W2791443664 hasConcept C203165030 @default.
• W2791443664 hasConcept C22070199 @default.
• W2791443664 hasConcept C2522874641 @default.
• W2791443664 hasConcept C2778540732 @default.
• W2791443664 hasConcept C2779141303 @default.
• W2791443664 hasConcept C2779261636 @default.
• W2791443664 hasConcept C2780801004 @default.
• W2791443664 hasConcept C2780868878 @default.
• W2791443664 hasConcept C2908647359 @default.
• W2791443664 hasConcept C71924100 @default.
• W2791443664 hasConcept C83455156 @default.
• W2791443664 hasConcept C99454951 @default.
• W2791443664 hasConceptScore W2791443664C121332964 @default.
• W2791443664 hasConceptScore W2791443664C12590561 @default.
• W2791443664 hasConceptScore W2791443664C1276947 @default.
• W2791443664 hasConceptScore W2791443664C159047783 @default.
• W2791443664 hasConceptScore W2791443664C159654299 @default.
• W2791443664 hasConceptScore W2791443664C203014093 @default.
• W2791443664 hasConceptScore W2791443664C203165030 @default.
• W2791443664 hasConceptScore W2791443664C22070199 @default.
• W2791443664 hasConceptScore W2791443664C2522874641 @default.
• W2791443664 hasConceptScore W2791443664C2778540732 @default.
• W2791443664 hasConceptScore W2791443664C2779141303 @default.
• W2791443664 hasConceptScore W2791443664C2779261636 @default.
• W2791443664 hasConceptScore W2791443664C2780801004 @default.
• W2791443664 hasConceptScore W2791443664C2780868878 @default.
• W2791443664 hasConceptScore W2791443664C2908647359 @default.
• W2791443664 hasConceptScore W2791443664C71924100 @default.
• W2791443664 hasConceptScore W2791443664C83455156 @default.
• W2791443664 hasConceptScore W2791443664C99454951 @default.
• W2791443664 hasIssue "11" @default.
• W2791443664 hasLocation W27914436641 @default.

• next